logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
delete
arrow
返回
N

Neal D. Shore

Carolina Urologic Research Center

84H指数
1.3K论文数
4.5W被引数
收录论文 390
发表时间
logo
Correspondence: persistence, progression, and PSA: what exactly does DEAR-EXT compare? Yanping Zhu, Xiaohui Wang, Yang Zhang, Shuangwu Lv通讯：持续性、进展和PSA：DEAR-EXT具体比较了什么？ 朱艳萍，王晓辉，张阳，吕双武
errProstate Cancer and Prostatic Diseases
IF5.8
err2026-08-18
err0
errOAAI
errNeal D. Shore; Daniel J. George; Nasreen Khan; Niculae Constantinovici; Guifang Chen; Mercedeh Ghadessi; Vlasta Hlebec; Alicia K. Morgans
err分享
err收藏
Enzalutamide in biochemically recurrent prostate cancer: clinical implications from EMBARK for real-world practice恩扎卢替尼在生物化学性复发性前列腺癌中的应用：EMBARK研究对真实世界实践的临床意义
errFuture Oncology
IF2.6
err2026-07-09
err0
errOAAI
errStephen J. Freedland; Neal D. Shore
err分享
err收藏
Real-world clinical outcomes and economic burden of discontinuation of taxane therapy among patients with metastatic castration-resistant prostate cancer转移性去势抵抗性前列腺癌患者紫杉烷疗法中断的真实世界临床结局和经济负担
errInternational Journal of Clinical Oncology
IF2.8
err2026-06-25
err0
errOAAI
errNeal Shore; Nguyen; Barinder Kang; Amrita Sawhney; Clare Byrne; Jackson Tang; Magdaliz Gorritz; Chi-Chang Chen; Jeetvan Patel
err分享
err收藏
Efficacy and safety of darolutamide plus androgen-deprivation therapy in Black patients with metastatic hormone-sensitive prostate cancer from the phase 3 ARANOTE trial达罗鲁胺联合雄激素剥夺疗法在黑种人转移性激素敏感性前列腺癌患者中的有效性与安全性：来自III期ARANOTE试验的数据
errProstate Cancer and Prostatic Diseases
IF5.8
err2026-06-20
err0
errOAAI
errQuoc-Dien Trinh; Daniel J. George; Neal Shore; Egils Vjaters; David Olmos; Andrea Juliana P. de Santana Gomes; Augusto Cesar de Andrade Mota; Natasha Littleton; Shankar Srinivasan; Frank Verholen; Kunhi Parambath Haresh; Fred Saad
err分享
err收藏
Phase III randomized studies of mevrometostat and enzalutamide in metastatic prostate cancer (MEVPRO-1 and MEVPRO-2): trial protocolsIII期随机研究评估美沃鲁莫司他和恩扎卢胺在转移性前列腺癌中的疗效（MEVPRO-1和MEVPRO-2）：试验方案
errFuture Oncology
IF2.6
err2026-05-10
err0
PREAI
errNeal D. Shore; Karim Fizazi; Michael Thomas Schweizer; Elena Castro; Arun A. Azad; Daniel J. George; Karine Martins da Trindade; Hao Zeng; Nitin Shrivastava; Svitlana Tonkovyd; Amy Bock; Srilakshmi Nekkalapudi; Yiyun Tang; Stella Lin; Neeraj Agarwal
err分享
err收藏
DURVALUMAB IN COMBINATION WITH BACILLUS CALMETTE-GUéRIN FOR BACILLUS CALMETTE-GUéRIN-NAÏVE, HIGH-RISK NON-MUSCLE-INVASIVE BLADDER CANCER: PRIMARY RESULTS FROM A US-BASED, PHASE IIIB, OPEN-LABEL, SINGLE-ARM, MULTICENTER STUDY (PATAPSCO)度鲁妥木单抗联合卡介苗用于卡介苗初治、高危非肌层浸润性膀胱癌：一项美国进行的、IIIb期、开放标签、单臂、多中心研究（PATAPSCO）的主要结果
errJournal of Urology
IF6.8
err2026-05-01
err0
PREAI
errJayram, Gautam; Shore, Neal D.; Tyson, Mark; Pieczonka, Christopher; Treasure, Peter; Gadzinski, Adam; Mazzarella, Brian; Hodari, Moana; Glover, Kara; Hardikat, Sushant; Hahn, Noah M.
err分享
err收藏
Treatment of High-Risk Biochemically Recurrent Prostate Cancer With Enzalutamide in Combination With Leuprolide: Secondary End Points From the EMBARK Trial使用恩扎卢胺联合醋酸亮丙瑞林治疗高风险生化复发的前列腺癌：EMBARK试验的次要终点
errJournal of Urology
IF6.8
err2026-05-01
err6
PREAI
errShore, Neal D.; Gleave, Martin; De Giorgi, Ugo; Rannikko, Antti; Pieczonka, Christopher M.; Sridharan, Swetha; Brasso, Klaus; Woo, Henry H.; Gomez Caamano, Antonio; Saranchuk, Jeff W.; Nordquist, Luke T.; Ferreira, Ubirajara; Tang, Yiyun; Rosbrook, Brad; Haas, Gabriel P.; Rosales, Matt; Zohren, Fabian; Tarazi, Jamal; Freedland, Stephen J.
err分享
err收藏
Real-world treatment patterns in patients with biochemical recurrence after local prostate cancer therapy局部前列腺癌治疗后生化复发患者的真实世界治疗模式
errFuture Oncology
IF2.6
err2026-04-29
err0
errOAAI
errRana R. McKay; Nasreen Khan; Neal D. Shore; Guifang Chen; Vlasta Hlebec; Shankar Srinivasan; Daniel E. Spratt
err分享
err收藏
Health-related Quality of Life With ARPIs in mHSPC: Insights From a Network Meta-analysismHSPC中ARPIs相关的健康相关生活质量：来自网络Meta分析的研究启示
errEuropean Urology Focus
IF5.6
err2026-04-18
err0
errOAAI
errNeal D. Shore; Noman Paracha; Howard Thom; Philip Orishaba; Elaine Gallagher; Alicia K. Morgans
err分享
err收藏
Efficacy and safety of darolutamide in combination with androgen deprivation therapy and docetaxel in European patients from the phase 3 ARASENS trial达罗他胺联合雄激素剥夺疗法和多西他赛在欧洲患者中的疗效和安全性：来自III期ARASENS试验的数据
errEuropean Journal of Cancer
IF7.1
err2026-04-05
err0
PREAI
errBertrand Tombal; Maha Hussain; Fred Saad; Karim Fizazi; Neal Shore; Evgeny Kopyltsov; Martin Bögemann; Maria J Mendez-Vidal; Natasha Littleton; Shankar Srinivasan; Frank Verholen; Matthew R. Smith
err分享
err收藏
Association of race and survival in patients treated with apalutamide: Pooled analysis of two phase 3 trials种族与接受阿帕鲁他胺治疗患者生存期的关联：两项III期试验的合并分析
errCancer
IF5.1
err2026-01-01
err0
PREAI
errGebrael, Georges; Agarwal, Neeraj; Morgans, Alicia K.; Vince, Randy; Swami, Umang; Jia, Angela Y.; Zaorsky, Nicholas; Chehade, Chadi Hage; Ozay, Zeynep Irem; Malone, Shawn; Morgan, Scott C.; Wallis, Christopher J. D.; Kishan, Amar U.; Barata, Pedro C.; Chowdhury, Simon; Garcia, Jorge A.; Sheng, Iris; Brown, Jason R.; Small, Eric J.; Sun, Yilun; Shore, Neal D.; Saad, Fred; Spratt, Daniel E.; Roy, Soumyajit
err分享
err收藏
Strategies to Mitigate Breast-related Adverse Events in Patients with High-risk Biochemically Recurrent Prostate Cancer Receiving Enzalutamide Monotherapy: Perspectives and Challenges
errEuropean Urology Focus
IF5.6
err2025-12-18
err0
errOAAI
errNeal D. Shore; Stephen J. Freedland; Lisa G. Horvath; Joe M. O’Sullivan; Ugo De Giorgi; Edward C. Ray; Ashley E. Ross; Yiyun Tang; David Russell; Kenneth K. Iwata; Matt Rosales; Arijit Ganguli; Bertrand Tombal
err分享
err收藏
Early favorable prostate-specific antigen response prediction in metastatic hormone sensitive prostate cancer早期对转移性激素敏感型前列腺癌的 prostate-specific antigen (PSA) 阳性反应预测
errNature Communications
IF15.7
err2025-12-17
err0
errOAAI
errSoumyajit Roy; Yilun Sun; Maha Hussain; Kim N. Chi; Karim Fizazi; Ian D. Davis; Susan Halabi; Neeraj Agarwal; Simon Chowdhury; Bertrand Tombal; Scott C. Morgan; Shawn Malone; Pedro C. Barata; Michael Ong; Christopher J. D. Wallis; Alejandro Berlin; Umang Swami; Amar U. Kishan; Angela Y. Jia; Nicholas G. Zaorsky; Jorge A. Garcia; Prateek Mendiratta; Jason R. Brown; Vinod V. Subhash; Martin R. Stockler; Hayley Thomas; Rana R. McKay; Eric J. Small; Neal D. Shore; Fred Saad; Christopher J. Sweeney; Daniel E. Spratt
err分享
err收藏
Efficacy and safety of treatments for metastatic castration-sensitive prostate cancer: A comprehensive network meta-analysis including final ARANOTE data治疗转移性去势敏感前列腺癌的疗效与安全性：一项包含最终ARANOTE数据的综合网络Meta分析
errProstate Cancer and Prostatic Diseases
IF5.8
err2025-12-09
err0
errOAAI
errNeal Shore; Alicia K. Morgans; Noman Paracha; Elaine Gallagher; Howard Thom; David Aceituno; Philip Orishaba; Stephen Stefani; Quoc-Dien Trinh; Christopher J. D. Wallis; Keith R. Abrams; Martin Boegemann
err分享
err收藏
Response to Letter to the Editor Regarding: ‘Overall Survival with Apalutamide Versus Enzalutamide in Metastatic Castration-Sensitive Prostate Cancer'对关于“在转移性去势敏感型前列腺癌中阿帕鲁他胺对比恩扎鲁他胺的总生存期”的读者来信的回复
errAdvances in Therapy
IF4
err2025-11-28
err0
errOAAI
errMehmet A. Bilen; Benjamin Lowentritt; Ibrahim Khilfeh; Carmine Rossi; Shawn Du; Frederic Kinkead; Lilian Diaz; Dominic Pilon; Lorie Ellis; Neal D. Shore
err分享
err收藏
A roadmap for future clinical research in advanced prostate cancer: Findings from the Advanced Prostate Cancer Consensus Conference (APCCC) 2024未来晚期前列腺癌临床研究的路线图：2024年晚期前列腺癌共识会议（APCCC）的研究结果
errEuropean Journal of Cancer
IF7.1
err2025-11-21
err0
PREAI
errUrsula M. Vogl; Sara Merler; Antonio Angrisani; Fabio Turco; Ian D. Davis; Jason A. Efstathiou; Karim Fizazi; Nicholas D. James; Neal Shore; Eric J. Small; Matthew R. Smith; Christopher J. Sweeney; Bertrand Tombal; Thomas Zilli; Ken Herrmann; Aurelius Omlin; Silke Gillessen
err分享
err收藏
Enzalutamide with or without leuprolide in patients with high-risk biochemically recurrent prostate cancer: EMBARK post hoc analysis by age恩扎卢替尼联合或不联合亮丙瑞林治疗高危生化复发性前列腺癌患者：EMBARK研究事后分析按年龄分层
errEuropean Journal of Cancer
IF7.1
err2025-11-15
err0
PREAI
errNeal D. Shore; Ugo De Giorgi; Matko Kalac; Yiyun Tang; Ruslan Croitoru; Matt Rosales; Melissa J. Huynh; Igle J. de Jong; Christopher P. Evans; Flavio M. Carcano; Stephen J. Freedland
err分享
err收藏
Corrigendum to Talazoparib plus enzalutamide in metastatic castration-resistant prostate cancer: Safety analyses from the randomized, placebo-controlled, phase III TALAPRO-2 study [European Journal of Cancer Volume 213, December 2024, 115078]勘误：Talazoparib 联合 enzalutamide 治疗 metastatic castration-resistant prostate cancer 的安全性分析，来自随机、安慰剂对照、III 期 TALAPRO-2 研究的结果 [European Journal of Cancer Volume 213, December 2024, 115078]
errEuropean Journal of Cancer
IF7.1
err2025-11-13
err0
PREAI
errArun A. Azad; Karim Fizazi; Nobuaki Matsubara; Fred Saad; Ugo De Giorgi; Jae Young Joung; Peter C.C. Fong; Robert J. Jones; Stefanie Zschäbitz; Jan Oldenburg; Neal D. Shore; Curtis Dunshee; Joan Carles; Andre P. Fay; Xun Lin; Liza DeAnnuntis; Nicola Di Santo; Michael A. Zielinski; Neeraj Agarwal
err分享
err收藏
Prostate-specific Antigen and Objective Response Analyses in PROpel: Olaparib Plus Abiraterone Versus Placebo Plus Abiraterone as First-line Therapy for Metastatic Castration-resistant Prostate Cancer前列腺特异性抗原和客观缓解分析在PROpel研究中：奥拉帕利联合阿比特龙对比安慰剂联合阿比特龙作为转移性去势抵抗性前列腺癌的一线疗法
errEuropean Urology Oncology
IF9.3
err2025-11-04
err0
errOAAI
errFred Saad; Andrew J. Armstrong; Mototsugu Oya; Neal Shore; Giuseppe Procopio; João Daniel Guedes; Cagatay Arslan; Niven Mehra; Emma Brown; Jae Young Joung; Mikio Sugimoto; Oliver Sartor; Christian Poehlein; Elizabeth A. Harrington; Jinyu Kang; Noel Clarke
err分享
err收藏
Darolutamide plus androgen-deprivation therapy in high-risk biochemical recurrence of prostate cancer (ARASTEP)
errFUTURE ONCOLOGY
IF2.6
err2025-11-01
err0
PREAI
errMorgans, Alicia K.; Chehrazi-Raffle, Alex; Niazi, Tamim; Shore, Neal D.; Ross, Ashley E.; Roder, Andreas; Gomes, Andrea Juliana; Supiot, Stephane; Barthelemy, Philippe; Hatano, Koji; Ruiz, Carmen Belen Congregado; Yoshida, Soichiro; Herrera-Imbroda, Bernardo; Gratton, Matthieu; Gschwend, Jurgen E.; Hope, Thomas A.; Joensuu, Heikki; Kuss, Iris; Le Berre, Marie-Aude; Dimova-Dobreva, Miryana; Fizazi, Karim
err分享
err收藏

研究方向

暂时未获取到该数据
合作学者
合作期刊
M
Mark A. Rubin
H 指数: 186 · 论文数: 1.5K
H
Howard I. Scher
H 指数: 164 · 论文数: 1.4K
J
Johann S. de Bono
H 指数: 160 · 论文数: 2.5K
P
Peter R. Carroll
H 指数: 149 · 论文数: 1.4K
P
Peter T. Scardino
H 指数: 149 · 论文数: 1.2K
查看更多